Cancer Prevention Pharmaceuticals

Cancer Prevention Pharmaceuticals engages in the development and production of drugs to prevent cancer in populations at elevated risk for these diseases in the United States. The company provides difluoromethylornithine (DFMO) for clinical trials in cancer prevention and treatment. It also develops diagnostic methods to identify individuals at high risk for specific cancers and drug-related toxicities. Additionally, the company is advancing chemopreventive indications for common cancers as well as strategies for the prevention and treatment of certain rare cancers.